CSA – cannabis.co.nz

February 10, 2024280E, 280e marijuana, 280e tax code, All U.S., Canna Provisions, cannabis lawsuit, Cannabis tax, cannabis taxes, controlled substances act, CSA, finance, legal, Medical & Recreational, Section 280E, Trulieve

Opinion: Is Trulieve’s refund claim the cannabis industry’s way out of 280E?

Trulieve Cannabis Corp.’s highly publicized $143 million federal income tax refund claims created a frenzy of hope that seems to offer the […]

January 11, 20232022, 2023, Act, agencies, analysis, analytics, banking, Biden, Brownstein, Brownstein Hyatt Farber Schreck, business, Business Analysis, california, cannabis, Cannabis Opportunity Act, CAOA, cbd, challenge, CLIMB, compliance, consumer, controlled substances act, CSA, cultivation, department of justice, dispensary, DOJ, extraction, Federal, government, growing, Harnessing Opportunities by Pursuing Expungement, HOPE, industry, Joe, law, legal, legalization, legalize, legislation, license, LLP, marijuana, Marijuana Opportunity Reinvestment and Expungement, market, medical, medicine, MORE, New, pardon, president, product, Quality, recreational, regulation, regulations, regulatory, safe, safety, state, thc, the States Reform Act, year

Cannabis in 2023: Here to Stay, but Major Challenges Remain

2022 brought more change and visibility to the cannabis industry than nearly any year before. Two of five legalization ballot measures passed, […]

May 5, 2022Act, AML, analysis, analytics, bank, banking, BSA, business, Business Analysis, cannabis, cbd, CDD, civil, compliance, consumer, CRB, criminal, CSA, due diligence, EDD, Federal, finance, financial, government, growing, industry, lab, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, money, MORE, NBFI, penalties, product, recreational, regulation, regulations, regulatory, retail, risk, safe, schedule, transaction

Cannabis Banking: The Ins, the Outs & the Unknowns

As the legal cannabis market expands, banks and nonbank financial institutions (NBFIs) across the United States continue to explore how to safely […]

December 2, 2021280E, Act, analysis, analytics, business, Business Analysis, california, cannabis, cash, compliance, controlled, CSA, deduct, deduction, expense, Federal, finance, government, growing, industry, IRC, irs, law, legal, legalization, legalize, legislation, license, marijuana, market, MRB, Operations, payroll, product, recreational, regulation, regulations, regulatory, retail, revenue, schedule 1, state, substance, Substances, tax, taxation, taxes

How Section 280E is Still Hindering the Cannabis Industry

The cannabis industry is an unprecedented industry and one under constant review and control. Following the November 2020 elections, fifteen states and […]

August 26, 20211, Act, ADOR, ALTA, analysis, analytics, bank, banking, blockchain, BSA, business, Business Analysis, cannabis, cash, compliance, compliant, CRB, crypto, CSA, Dama, digital, DOJ, economic, economy, Federal, finance, financial, government, growing, industry, institution, laundering, law, legal, legalization, legalize, legislation, lending, license, loan, marijuana, market, MLCA, money, NaturePay, Partners Credit Union, product, recreational, regulation, regulations, regulatory, retail, risk, Safe Harbor, Safe Harbor Private Banking, schedule, state, trend

Current Trends in Banking for Cannabis-Related Businesses

Cannabis is still federally illegal and is included on Schedule 1 of the Controlled Substances Act (CSA), along with such other substances […]

August 25, 20212021, Act, analysis, analytics, baking, Bryan Johnson, business, cannabis, cannabis administration and opportunity act, CAOC, CDAPCA, compliance, CSA, dea, Federal, government, industry, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, recreational, regulation, regulatory, safe, state

Could 2021 Be the Year of Federal Cannabis Legalization?

The legalization of cannabis in the U.S. has been long in the making. Back in the early 1970s, states such as Oregon, […]

February 25, 2021analysis, analytics, business, cannabis, CAPA, cbd, cGMPs, compliance, compliant, consumer, cosmetics, CSA, cultivation, Current good manufacturing Practice, device, dietary supplements, dispensary, drug, Edibles & Processing, employee training, equipment design, extraction, facility design, FDA, Federal, food, GMP, GMPs, good manufacturing practice, government, growing, industry, Kathleen May, lab, laboratories, laboratory, labs, law, legal, legalization, legalize, marijuana, market, medical, medicine, Operations, product, Quality, regulation, regulations, regulatory, risk management, safety, schedule I, standard, state, Supply Chain, system, test, Testing, thc, Triskele Quality Solutions, USDA

GMPs & Cannabis Manufacturing

Editor’s Note: While CIJ typically omits the word “marijuana” where possible due to antiquated nomenclature and prejudicial connotations, we understand the legal […]

October 28, 20201, analysis, analytics, and Cosmetics Act, application, approval, approve, business, Business Analysis, cannabidiol, cannabis, cbd, clinical, clinical trials, compliance, consumer packaged goods, CPG, CSA, dea, derived, deschedule, descheduled, Dravet syndrome, drug, Drug Enforcement Administration, Epidiolex, epilepsy, extraction, FDA, FDCA, Federal, Federal Food, FFDCA, food and drug administration, formulation, government, GW, GW Pharma, hemp, industry, law, legal, legalization, legalize, legislation, Lennox-Gastaut syndrome, license, marijuana, market, medical, medicine, New, patent, pathway, patient, pharma, pharmaceutical, product, Product Development, program, regulation, regulations, regulatory, REMS, safety, schedule, seizures, state, Substances, thc, trial, TSC

How GW Pharma Won CBD

As of this writing, the United States Food and Drug Administration (FDA) has approved GW Pharma’s CBD drug Epidiolex for treating profound […]